Cognitive impairment is a significant clinical problem both in multiple sclerosis (MS) and systemic lupus erythematosus (SLE) patients. In MS cognitive dysfunction has been associated with brain atrophy and total demyelinating lesion volume. In SLE cognitive impairment is much less understood, and its link to structural brain damage remains to be established. The aim of this study was to identify the relationship between subcortical gray matter volume and cognitive impairment in MS and SLE. We recruited 37 MS and 38 SLE patients matched by age, disease duration and educational level. Patients underwent magnetic resonance imaging (MRI) and a battery of psychometric tests. Severity of cognitive impairment was similar in both cohorts despite larger white matter lesion load in MS patients. Psychometric scores were associated with global and subcortical gray matter atrophy measures and lesion load in MS, but not in SLE. In SLE, the lack of a relationship between cognitive impairment and structural damage, defined either as atrophy or white matter lesions, indicates a different causal mechanism of cognitive deficit.
GeurtsJJCalabreseMFisherERudickRA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol2012; 11: 1082–1092.
2.
BenedictRHWeinstock-GuttmanBFishmanISharmaJTjoaCWBakshiR. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol2004; 61: 226–230.
3.
RaoSMLeoGJBernardinLUnverzagtF. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
4.
BenedictRCookfairDGavettRet al.Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc2006; 12: 549–558.
5.
AmatoMPPonzianiGSiracusaGSorbiS. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol2001; 58: 1602–1606.
6.
ChiaravallotiNDDeLucaJ. Cognitive impairment in multiple sclerosis. Lancet Neurol2008; 7: 1139–1151.
7.
DeLucaJLeavittVMChiaravallotiNWylieG. Memory impairment in multiple sclerosis is due to a core deficit in initial learning. J Neurol2013; 260: 2491–2496.
8.
BeverCTGrattanLPanitchHSJohnsonKP. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: A preliminary serial study. Mult Scler1995; 1: 165–169.
9.
LangdonDWAmatoMPBoringaJet al.Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler2012; 18: 891–898.
10.
ChristodoulouCKruppLBLiangZet al.Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology2003; 60: 1793–1798.
11.
RossiFGiorgioABattagliniMet al.Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLoS One2012; 7: e44826–e44826.
12.
ArnettPARaoSMBernardinLGrafmanJYetkinFZLobeckL. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology1994; 44: 420–425.
13.
BenedictRHShucardJLZivadinovRShucardDW. Neuropsychological impairment in systemic lupus erythematosus: A comparison with multiple sclerosis. Neuropsychol Rev2008; 18: 149–166.
14.
AlexanderGEDeLongMRStrickPL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci1986; 9: 357–381.
15.
CoveyTJShucardJLShucardDWStegenSBenedictRH. Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients. J Int Neuropsychol Soc2012; 18: 530–540.
16.
MiddletonFAStrickPL. Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies. Brain Cogn2000; 42: 183–200.
17.
PeraniD. Functional neuroimaging of cognition. Handb Clin Neurol2008; 88: 61–111.
18.
PolmanCHReingoldSCEdanGet al.Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
19.
NivedOSturfeltGLiangMDe PabloP. The ACR nomenclature for CNS lupus revisited. Lupus2003; 12: 872–876.
20.
ZhangYBradyMSmithS. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging2001; 20: 45–57.
HuijbregtsSCKalkersNFde SonnevilleLMde GrootVReulingIEPolmanCH. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology2004; 63: 335–339.
23.
SpreenOStraussE. A compendium of neuropsychological tests: Administration, norms, and commentary., 2nd ed. NY: Oxford University Press, 1998.
24.
CarterPJ. The complete book of intelligence tests, UK: Wiley, 2005.
25.
BroshekDBarthJThe Halstead-Reitan Neuropsychological Test Battery. In: Groth-MarnatG (ed). Neuropsychological assessment in clinical practice: A guide to test interpretation and integration, NY: John Wiley and Sons, 2000.
26.
BeckATWardCHMendelsonMMockJErbaughJ. An inventory for measuring depression. Arch Gen Psychiatry1961; 4: 561–571.
27.
JaraczKWołowickaLBączykG. Validation analysis of the Polish version of the Ferrans and Powers Quality of Life Index. Post Rehab2001; 15: 67–73.
28.
Kalinowska-ŁyszczarzAPawlakMAMichalakSLosyJ. Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients. J Neurol Sci2012; 321: 43–48.
Pravatà E, Rocca MA, Valsasina P, et al. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Mult Scler. Epub ahead of print 1 February 2017. DOI: 10.1177/1352458517692886.
31.
FaustTWChangEHKowalCet al.Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A2010; 107: 18569–18574.
32.
KowalCDiamondB. Aspects of CNS lupus: Mouse models of anti-NMDA receptor antibody mediated reactivity. Methods Mol Biol2012; 900: 181–206.
33.
KozoraEWestSGMaierSFet al.Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci2010; 295: 87–91.
34.
LuyendijkJSteensSCOuwendijkWJet al.Neuropsychiatric systemic lupus erythematosus: Lessons learned from magnetic resonance imaging. Arthritis Rheum2011; 63: 722–732.
35.
Steup-BeekmanGMZirkzeeEJCohenDet al.Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis2013; 72(Suppl 2): ii76–ii79.
36.
OgasawaraAKakedaSWatanabeKet al.Quantitative susceptibility mapping in patients with systemic lupus erythematosus: Detection of abnormalities in normal-appearing basal ganglia. Eur Radiol2016; 26: 1056–1063.
37.
BermelRABakshiRTjoaCPuliSRJacobsL. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol2002; 59: 275–280.
38.
BrassSDBenedictRHWeinstock-GuttmanBMunschauerFBakshiR. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler2006; 12: 437–444.
39.
PreziosaPRoccaMAPaganiEet al.Structural MRI correlates of cognitive impairment in patients with multiple sclerosis. Hum Brain Mapp2016; 37: 1627–1644.
40.
DebernardLMelzerTRAllaSet al.Deep grey matter MRI abnormalities and cognitive function in relapsing–remitting multiple sclerosis. Psychiatry Res2015; 234: 352–361.
41.
BergslandNZivadinovRDwyerMGWeinstock-GuttmanBBenedictRH. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult Scler2016; 22: 1327–1336.
42.
ModicaCMZivadinovRDwyerMGBergslandNWeeksARBenedictRH. Iron and volume in the deep gray matter: Association with cognitive impairment in multiple sclerosis. Am J Neuroradiol2015; 36: 57–62.
43.
SperlingRAGuttmannCRHoholMJet al.Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: A longitudinal study. Arch Neurol2001; 58: 115–121.
44.
FilippiMTortorellaCRovarisMet al.Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry2000; 68: 157–161.
45.
DeloireMSSalortEBonnetMet al.Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry2005; 76: 519–526.
46.
RocaMTorralvaTMeliFet al.Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts. Mult Scler2008; 14: 364–369.
47.
ZivadinovRBrownMHSchirdaCVet al.Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis. Neuroimage2012; 59: 331–339.
48.
JungRESegallJMGraziopleneRGQuallsCSibbittWLRoldanCA. Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus. PLoS One2010; 5: e9302–e9302.
49.
ZimmermannNCorrêaDGNettoTMet al.Episodic memory impairment in systemic lupus erythematosus: Involvement of thalamic structures. Clin Rheumatol2015; 34: 255–261.
50.
RenTHoRCMakA. Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus. Arthritis Rheum2012; 64: 4048–4059.
51.
ZimmermannNCorrêaDGKuboTAet al.Global Cognitive Impairment in Systemic Lupus Erythematosus Patients: A Structural MRI Study. Clin Neuroradiol2017; 27: 23–29.
